Atkinson Edward Morrow III 4
4 · VERTEX PHARMACEUTICALS INC / MA · Filed Nov 19, 2025
Insider Transaction Report
Form 4
Atkinson Edward Morrow III
EVP, Chief Technical Ops. Off.
Transactions
- Sale
Common Stock
2025-11-17$434.58/sh−2,500$1,086,450→ 16,852 total
Footnotes (1)
- [F1]Transaction made pursuant to Mr. Atkinson's company approved trading plan under Rule 10b5-1, which was entered into on 08/11/2025.